IBDEI12K ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19148,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,19148,1,5,0)
 ;;=5^Metatarsalgia
 ;;^UTILITY(U,$J,358.3,19148,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,19149,0)
 ;;=355.6^^125^1229^10
 ;;^UTILITY(U,$J,358.3,19149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19149,1,3,0)
 ;;=3^355.6
 ;;^UTILITY(U,$J,358.3,19149,1,5,0)
 ;;=5^Morton's metatarsalgia, neuralgia, or neuroma
 ;;^UTILITY(U,$J,358.3,19149,2)
 ;;=               ^268517
 ;;^UTILITY(U,$J,358.3,19150,0)
 ;;=736.79^^125^1229^7
 ;;^UTILITY(U,$J,358.3,19150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19150,1,3,0)
 ;;=3^736.79
 ;;^UTILITY(U,$J,358.3,19150,1,5,0)
 ;;=5^Metatarsal adductus/varus; Acquired
 ;;^UTILITY(U,$J,358.3,19150,2)
 ;;=^272742
 ;;^UTILITY(U,$J,358.3,19151,0)
 ;;=754.53^^125^1229^8
 ;;^UTILITY(U,$J,358.3,19151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19151,1,3,0)
 ;;=3^754.53
 ;;^UTILITY(U,$J,358.3,19151,1,5,0)
 ;;=5^Metatarsal adductus/varus; Congenital
 ;;^UTILITY(U,$J,358.3,19151,2)
 ;;=^273007
 ;;^UTILITY(U,$J,358.3,19152,0)
 ;;=355.8^^125^1229^9
 ;;^UTILITY(U,$J,358.3,19152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19152,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,19152,1,5,0)
 ;;=5^Mononeuritis of lower limb, unspecified
 ;;^UTILITY(U,$J,358.3,19152,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,19153,0)
 ;;=729.1^^125^1229^11
 ;;^UTILITY(U,$J,358.3,19153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19153,1,3,0)
 ;;=3^729.1
 ;;^UTILITY(U,$J,358.3,19153,1,5,0)
 ;;=5^Myalgia and myositis, unspecified
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=355.71^^125^1230^4
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19154,1,3,0)
 ;;=3^355.71
 ;;^UTILITY(U,$J,358.3,19154,1,5,0)
 ;;=5^Nerve entrapment, lower limb
 ;;^UTILITY(U,$J,358.3,19154,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,19155,0)
 ;;=216.7^^125^1230^2
 ;;^UTILITY(U,$J,358.3,19155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19155,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,19155,1,5,0)
 ;;=5^Neoplasm, skin of lower limb, including hip; Benign
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=239.2^^125^1230^3
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19156,1,3,0)
 ;;=3^239.2
 ;;^UTILITY(U,$J,358.3,19156,1,5,0)
 ;;=5^Neoplasm, skin, bone and soft tissue; Unspecified
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=356.9^^125^1230^7
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19157,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,19157,1,5,0)
 ;;=5^Neuropathy, peripheral, Hereditary; Unspecified
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=355.8^^125^1230^8
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19158,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,19158,1,5,0)
 ;;=5^Neuropathy, peripheral, lower limb; Unspecified
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=356.2^^125^1230^5
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19159,1,3,0)
 ;;=3^356.2
 ;;^UTILITY(U,$J,358.3,19159,1,5,0)
 ;;=5^Neuropathy, Hereditary sensory
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^56583
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=714.0^^125^1230^9
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19160,1,3,0)
 ;;=3^714.0
 ;;^UTILITY(U,$J,358.3,19160,1,5,0)
 ;;=5^Nodules, rheumatoid arthritis
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^10473
